The effect of perioperative insulin treatment on cardiodepression in mild adiposity in mice

Cardiovascular Diabetology

Volumn 15, Issue 1, 2016, Pages

  Boly, Chantal A ^a   Eringa, Etto C ^a   Bouwman, R Arthur ^b   den Akker, Rob F P ^a   de Man, Frances S ^a   Schalij, Ingrid ^a   Loer, Stephan A ^a   Boer, Christa ^a   van den Brom, Charissa E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

Adiposity; Insulin; Myocardial contraction; Myocardial perfusion; Perioperative period

Indexed keywords

ACEPROMAZINE; FENTANYL; INSULIN; MIDAZOLAM; ANTIDIABETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CONTINUOUS INFUSION; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DIET INDUCED OBESITY; GENERAL ANESTHESIA; HEART AFTERLOAD; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE PERFUSION; HEMODYNAMIC PARAMETERS; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN TREATMENT; MALE; MOUSE; MYOCARDIAL DEPRESSION; MYOCARDIAL DISEASE; NONHUMAN; PERIOPERATIVE PERIOD; THORACOTOMY; VENTRICULO ARTERIAL COUPLING; WESTERN DIET; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; COMPLICATION; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC IMAGING; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECTS; ECHOCARDIOGRAPHY; HEART DISEASES; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; METABOLOMICS; OBESITY; PATHOPHYSIOLOGY; PEROPERATIVE CARE; SEVERITY OF ILLNESS INDEX; SURGERY; WEIGHT GAIN;

ADIPOSITY; ANESTHESIA, GENERAL; ANIMALS; CORONARY CIRCULATION; DIET, WESTERN; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY; HEART DISEASES; HYPOGLYCEMIC AGENTS; INSULIN; INTRAOPERATIVE CARE; MALE; METABOLOMICS; MICE, INBRED C57BL; OBESITY; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX; SURGICAL PROCEDURES, OPERATIVE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE; WEIGHT GAIN;

EID: 84988613811     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-016-0453-y     Document Type: Article

References (40)

1. Scharwächter WH, Keet SWM, Stoecklein K, Loer SA, Boer C. Health risk factors in the anesthesia population. J Clin Anesth. 2016;32:33-9.
2. Alpert MA, Lavie CJ, Agrawal H, Kumar A, Kumar SA. Cardiac effects of obesity: pathophysiologic, clinical and prognostic consequences-a review. J Cardiopulm Rehabil Prev. 2016;36:1-11.
3. Schindler TH, Cardenas J, Prior JO, et al. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol. 2006;47:1188-95.
4. Candiotti K, Sharma S, Shankar R. Obesity, obstructive sleep apnea, and diabetes mellitus: anesthetic implications. Br J Anaesth. 2009;103:i23-30.
5. Hodgson LE, Murphy PB, Hart N. Respiratory management of the obese patient undergoing surgery. J Thorac Dis. 2015;7:943-52.
6. Tzimas P, Petrou A, Laou E, et al. Impact of metabolic syndrome in surgical patients: should we bother? Br J Anaesth. 2015;115:194-202.
7. Bussey CT, de Leeuw AE, Lamberts RR. Increased hemodynamic adrenergic load with isoflurane anesthesia in type 2 diabetic and obese rats in vivo. Cardiovasc Diabetol. 2014;13:161.
8. Van den Brom CE, Boly CA, Bulte CS, van den Akker RF, Kwekkeboom RF, Loer SA, Boer C, Bouwman RA. Myocardial perfusion and function are distinctly altered by sevoflurane anesthesia in diet-induced prediabetic rats. J Diabetes Res. 2015. doi: 10.1155/2016/5205631.
9. Holger JS, Dries DJ, Barringer KW, Peake BJ, Flottemesch TJ, Marini JJ. Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model. Acad Emerg Med. 2010;17:429-35.
10. Soliman M. Insulin treatment before resuscitation following hemorrhagic shock improves cardiac contractility and protects the myocardium in the isolated rat heart. J Emerg Trauma Shock. 2015;8:144-8.
11. Fan Y, Zhang AM, Xiao YB, Weng YG, Hetzer R. Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis. Eur J Cardiothorac Surg. 2011;40:192-9.
12. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.
13. van den Brom CE, Bulte CS, Kloeze BM, Loer SA, Boer C, Bouwman RA. High fat diet-induced glucose intolerance impairs myocardial function, but not myocardial perfusion during hyperaemia: a pilot study. Cardiovasc Diabetol. 2012;11:74.
14. Bulte CS, Slikkerveer J, Meijer RI, et al. Contrast-enhanced ultrasound for myocardial perfusion imaging. Anesth Analg. 2012;114:938-45.
15. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol. 2005;289:H501-12.
16. de Boer MP, Meijer RI, Richter EA, et al. Globular adiponectin controls insulin-mediated vasoreactivity in muscle through AMPKα2. Vascul Pharmacol. 2016;78:24-35.
17. Abdesselam I, Pepino P, Troalen T, et al. Time course of cardiometabolic alterations in a high fat high sucrose diet mice model and improvement after GLP-1 analog treatment using multimodal cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2015;17:95.
18. Soliman H, Nyamandi V, Garcia-Patino M, et al. Partial deletion of ROCK2 protects mice from high-fat diet-induced cardiac insulin resistance and contractile dysfunction. Am J Physiol Heart Circ Physiol. 2015;309:H70-81.
19. van Haare J, Kooi ME, Vink H, et al. Early impairment of coronary microvascular perfusion capacity in rats on a high fat diet. Cardiovasc Diabetol. 2015;14:150.
20. Mourmoura E, Chate V, Couturier K, et al. Body adiposity dictates different mechanisms of increased coronary reactivity related to improved in vivo cardiac function. Cardiovasc Diabetol. 2014;13:54.
21. Heusch G. The regional myocardial flow-function relationship: a framework for an understanding of acute ischemia, hibernation, stunning and coronary microembolization. Circ Res. 2013;112:1535-7.
22. Gamez-Mendez AM, Vargas-Robles H, Rios A, Escalante B. Oxidative stress-dependent coronary endothelial dysfunction in obese mice. PLoS ONE. 2015;10:e0138609.
23. Quercioli A, Pataky Z, Montecucco F, et al. Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. JACC Cardiovasc Imaging. 2012;5:805-15.
24. Quercioli A, Montecucco F, Pataky Z, et al. Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. Eur Heart J. 2013;34:2063-73.
25. Hink U, Li H, Mollnau H, Oelze M, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001;88:E14-22.
26. Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab. 1999;84:3212-6.
27. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96:1152-6.
28. Ma H, Zhang HF, Yu L, Zhang QJ, Li J, Huo JH, et al. Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: role of Akt-stimulated NO production. Cardiovasc Res. 2006;69:57-65.
29. Howell NJ, Ashrafian H, Drury NE, et al. Glucose-insulin-potassium reduces the incidence of low cardiac output episodes after aortic valve replacement for aortic stenosis in patients with left ventricular hypertrophy: results from the Hypertrophy, Insulin, Glucose, and Electrolytes (HINGE) trial. Circulation. 2011;123:170-7.
30. Lazar HL. Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GIK) solutions. Am J Cardiol. 1997;80:90A-3A.
31. Duncan AE, Kateby KB, Sarwar S, et al. Hyperinsulinemic normoglycemia does not meaningfully improve myocardial performance during cardiac surgery: a randomized trial. Anesthesiology. 2015;123:272-87.
32. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31:359-66.
33. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89:1191-8.
34. Quinn DW, Pagano D, Bonser RS, et al. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg. 2006;131:34-42.
35. Ranasinghe AM, Quinn DW, Pagano D, et al. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation. 2006;114:I245-50.
36. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg. 2000;70:145-50.
37. Sato H, Hatzakorzian R, Carvalho G, et al. High-dose insulin administration improves left ventricular function after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2011;25:1086-91.
38. Zhang HF, Fan Q, Qian XX, et al. Role of insulin in the anti-apoptotic effect of glucose-insulin-potassium in rabbits with acute myocardial ischemia and reperfusion. Apoptosis. 2004;9:777-83.
39. Liu Z. Insulin at physiological concentrations increases microvascular perfusion in human myocardium. Am J Physiol Endocrinol Metab. 2007;293:E1250-5.
40. Pirracchio R, Cholley B, De HS, Solal AC, Mebazaa A. Diastolic heart failure in anesthesia and critical care. Br J Anaesth. 2007;98:707-21.